No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Abingdon Health announced on Wednesday that it has deepened its strategic relationship with US-based diagnostics firm Find Out From Home (FOFH), appointing company president Chris Yates as a director of FOFH.
The AIM-listed rapid test developer and manufacturer holds a 19% stake in FOFH through a service-for-equity arrangement, and was supporting the US company's product development and regulatory efforts.
Abingdon and FOFH are currently working on gaining regulatory approval for four self-test kits targeting sexually transmitted diseases, under a $2m contract announced in December.
In addition, the two companies were collaborating on the development of a further three STD tests.
At 1030 BST, shares in Abingdon Health were down 2.43% at 6.83p.
Reporting by Josh White for Sharecast.com.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.